Bibliography
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn, text revision) (DSM-IV-TR). American Psychiatric Press, Washington, DC; 2000
- Schwärzler B, Hautzinger M. Premenstrual dysphoric disorder: a proposed diagnostic method of a distinct affective disorder. Der Nervenarzt 2002;73(1):65-70
- Mchichialami KH, Tahiri SM, Moussaoui D, et al. Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca. Encephale 2002;28(6):525-30
- Wittchen HU, Becker E, Lieb R, et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002;32:119-32
- Cross GB, Marley J, Miles H, et al. Changes in nutrient intake during the menstrual cycle of overweight women with premenstrual syndrome. Br J Nutr 2001;85(4):475-82
- Pearlstein T, Stone AB. Premenstrual syndrome. Psychiatr Clin North Am 1998;21:577-90
- Bianchi-Demicheli F, Lüdicke F, Lucas H, et al. Premenstrual dysphoric disorder: current status of treatment. Swiss Med Weekly 2002;132:574-8
- Hsiao MC, Liu CY. Effective open-label treatment of premenstrual dysphoric disorder with venlafaxine. Psych Clin Neurosci 2003;57:317-21
- Freeman EW, Rickels K. Characteristics of placebo responses in medical treatment of premenstrual syndrome. Am J Psychiatry 1999;156:1403-8
- Pearlstein TB, Bellew KM, Endicott J, et al. Paroxetine controlled release for premenstrual dysphoric disorder: remission analysis following a randomised, double-blind, placebo-controlled trial. J Clin Psychiatry 2005;7:53-60
- Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22-33
- World Health Organization. International Classification of Disease (10th edition, ICD-10). WHO; 1994
- Steiner M, Streiner DL, Steinberg, et al. The measurement of premenstrual mood symptoms. J Aff Disord 1999;53:269-73
- Steiner M, Streiner DL, Pham B. Validation of a revised visual analog scale for premenstrual mood symptoms: results from prospective and retrospective trials. Can J Psychiatry 2005;50:327-32
- Mishell DR. Premenstrual disorders: epidemiology and disease burden. Am J Manag Care 2005;11:S473-9
- Steiner M, Pearlstein T. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment. J Clin Psychiatry 2000;61(S12):17-21
- Freeman EW, Rickels K, Yonkers KA, et al. Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol 2001;98:737-44
- Blake F, Salkovskis P, Gath D, et al. Cognitive therapy for premenstrual syndrome: a controlled trial. J Psychosom Res 1998;45:307-18
- Dimmock PW, Wyatt KM, Jones PW, et al. Efficacy of selective serotonin-re-uptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000;356:1131-6
- Landen M, Nissbrandt H, Allgulander C, et al. Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder. Neuropsychopharmacology 2007;32:153-61
- Cohen LS, Soares CN, Yonkers KA, et al. Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial. Psychosom Med 2004;66:707-13
- Ramos MG, Hara C, Rocha FL. Duloxetine treatment of premenstrual dysphoric disorder: case reports. Progr Neuropsychopharmacol Biol Psychiatry Epub 2007 Sep 15
- Frampton JE, Plosker GL. Duloxetine: a review of its use in the treatment of major depressive disorder. CNS Drugs 2007;21(7):581-609
- Brannan SK, Mallinckrodt CH, Brown EB, et al. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatr Res 2005;39:43-53